Science
Switching off cellular recycling gene increases yields of hard-to-make drug target proteins
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 18/11/2026, 22:40:08 UTC
Briefing created: 18/11/2026, 23:03:44 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 18/11/2026, 22:40:24 UTC.
Briefings
Researchers disabled cellular recycling systems to increase protein production for drug targets. This approach could accelerate drug development by reducing costs and accelerating the discovery of new medicines.
Key points
- A genetic modification disabled cells' recycling systems to increase protein production.
- The findings suggest this method could speed up drug development while reducing R&D costs.
Context
This study represents a novel approach to pharmaceutical manufacturing by manipulating cellular machinery to enhance protein synthesis for drug discovery.
Limitations
Evidence is limited to a single study published in 2026. Results are preliminary and may vary across different cell types or conditions.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 18/11/2026, 23:03:44 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeibkojmyunk44zs2fecjb5dw4y2h5hdude5rffpieoa7bttgfpsm7i